Related Experiment Videos
Hyperthermic potentiation of cisplatin cytotoxicity on solid Ehrlich carcinoma
Osman A el-M1, M M Ahmed, M T Khayyal
1Cancer Biology Department, National Cancer Institute, Cairo University, Egypt.
Tumori
|August 31, 1993
Summary
Hyperthermia combined with cisplatin significantly enhances cancer treatment by increasing drug penetration and inhibiting tumor cell DNA repair. This synergistic effect leads to a substantial decrease in tumor volume and improved therapeutic outcomes.
Area of Science:
- Oncology
- Biochemistry
- Cancer Research
Background:
- Hyperthermia affects tumor cell biochemistry and potentiates drug efficacy.
- Solid Ehrlich carcinoma is a model for evaluating combined cancer therapies.
Purpose of the Study:
- To evaluate the synergistic effect of hyperthermia and cisplatin on solid Ehrlich carcinoma.
- To assess the impact on tumor growth and various cellular damage markers.
Main Methods:
- Solid Ehrlich carcinoma treated with hyperthermia (43°C for 30 min daily for 3 days) or cisplatin (5 mg/kg x 3).
- Combined treatment involved administering cisplatin 1 hour before hyperthermia.
- Biochemical parameters including DNA, RNA, protein, lipids, cholesterol, acid-phosphatase, and acid-ribonuclease were measured.
Main Results:
- Hyperthermia alone decreased tumor volume by 41.5% and affected cellular parameters.
- Cisplatin alone showed a slower tumor growth rate compared to controls.
- Combined treatment resulted in an 82.6% decrease in tumor volume, intensifying all measured effects.
Conclusions:
- Hyperthermia potentiates cisplatin's anti-tumor activity against solid Ehrlich carcinoma.
- Enhanced cisplatin penetration and inhibition of DNA repair are proposed mechanisms for synergy.
- Combination therapy offers a significantly more effective approach than monotherapy.